Accelerated cancer registration from the National Disease Registration Service to support the NHS-Galleri trial

Read full text Summarise with VIRAT
Authors: Charlotte Eversfield, Natalia Petersen, Rebecca Smittenaar, Wei Liang, Carlos Rocha, Lauren Harrop, Karen Graham, Nathaniel Dilling, Oliver Tulloch, Donna Lloyd, Peter David Sasieni, Brian Rous
+2 more Martine Bomb, Sean McPhail
Cited by: 0
References: 5

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Purpose High-quality population-based cancer registration data is crucial for cancer research. We describe the methodology that the National Disease Registration Service (NDRS) established to accelerate provision of cancer registration data in England to support timely analysis of the NHS-Galleri trial ( NCT05611632 ), assessing the clinical utility of a multi-cancer early detection test for population screening. Methods NDRS established two accelerated cancer registration products for trial participants: ‘Expedited Core’ (providing complete stage data 6 months after diagnosis) and ‘Expedited Comprehensive’ (providing ≥6 months of follow-up clinical pathway data 11 months after diagnosis). NDRS used pre-existing data sources and methodology, plus enhanced dedicated data liaison support. Timeliness and concordance of accelerated data was assessed 6, 11, and ≥19 months after diagnosis. Results At 6–10 months after diagnosis, most (98.0%) registrations achieved Expedited Core status; at >10 months, all (100%) registrations were Expedited Comprehensive. For fact of malignant cancer and stage III/IV diagnoses, concordance between registrations at 6 and ≥19 months was 96.7% and 95.6%, respectively. Conclusions NDRS delivered staged cancer registration data 6 months after diagnosis. High concordance at 6, 11, and 19 months provides confidence in the accelerated data. This supports reporting NHS-Galleri findings more promptly than possible via routine data. Highlights NDRS accelerated cancer registration data provision to support a major clinical trial Routine cancer registration data is typically available 18–20 months after diagnosis Accelerated staged cancer registration data was available 6 months after diagnosis Six, 11 & 19-month data concordance was high, indicating good data quality This data successfully supported trial analyses but required additional resource

Fields of Study & Subjects

Global Cancer Incidence and Screening Medical Coding and Health Information Electronic Health Records Systems

Publication details

Journal / source
medRxiv
Publication date
25 March 2026
Language
EN
Document type
Preprint